|
Real-time Estimate
Cboe BZX
14:57:40 05/03/2026 GMT
|
5-day change
|
1st Jan Change
|
|
182.26 USD
|
+1.50%
|
 |
+3.34%
|
-9.10%
|
|
02-18 |
Charles River Laboratories International, Inc. Announces Executive Appointments
|
CI
| |
02-18 |
Charles River forecasts upbeat 2026 profit on improved demand for drug development services
|
RE
| |
02-18 |
Charles River Q4 Adjusted Earnings, Revenue Decline; New CFO Named
|
MT
| |
01-12 |
Charles River Laboratories Reports Two Planned Acquisitions; Names Namandje Bumpus as Chief Scientific and Innovation Officer
|
MT
| |
01-12 |
Charles River Laboratories Names Dr. Namandjé N. Bumpus as Senior Vice President, Chief Scientific and Innovation Officer
|
CI
| |
01-08 |
Charles River Laboratories International, Inc. Announces Chief Executive Officer Changes
|
CI
| |
01-08 |
Charles River Laboratories International, Inc. Announces Changes in Board
|
CI
| |
01-08 |
Charles River Laboratories International, Chair, President, CEO James Foster to Retire
|
MT
| |
01-08 |
Charles River Laboratories announces planned retirement of James C. Foster
|
RE
| |
15/10/25 |
Charles River Announces Scientific Advisory Board to Drive Alternative Method Innovation and Adoption
|
CI
| |
16/09/25 |
Charles River Laboratories announces chief financial officer transition
|
RE
| |
16/09/25 |
Charles River Laboratories International, Inc. Announces Resignation of Flavia H. Pease, Corporate Executive Vice President from Her Role, Effective September 29, 2025
|
CI
| |
16/09/25 |
Charles River Laboratories International, Inc. Announces Chief Financial Officer Transition
|
CI
| |
16/09/25 |
Charles River Laboratories Says CFO to Step Down
|
MT
| |
16/09/25 |
Insulet Appoints Flavia Pease Finance Chief
|
MT
| |
07/05/25 |
Charles River to add new directors, review business in agreement with Elliott
|
RE
| |
07/05/25 |
Charles River Laboratories International, Inc. Announces Board Changes
|
CI
| |
12/02/25 |
Surgical Innovations profit boosted in second half, names new CFO
|
AN
| |
12/11/24 |
Charles River Laboratories International Insider Sold Shares Worth $1,647,418, According to a Recent SEC Filing
|
MT
| |
12/08/24 |
Charles River Laboratories International Insider Sold Shares Worth $354,861, According to a Recent SEC Filing
|
MT
| |
04/03/24 |
Charles River Laboratories International Insider Sold Shares Worth $959,545, According to a Recent SEC Filing
|
MT
| |
01/03/24 |
Charles River Laboratories International Insider Sold Shares Worth $1,268,500, According to a Recent SEC Filing
|
MT
| |
24/01/24 |
Charles River Laboratories International, Inc. Appoints Reshema Kemps-Polanco to Board of Directors
|
CI
| |
16/01/24 |
Charles River Laboratories International, Inc. Announces Executive Changes
|
CI
| |
18/12/23 |
Charles River Laboratories International Insider Sold Shares Worth $1,243,350, According to a Recent SEC Filing
|
MT
|
No results for this search Select your edition All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
| 
